Swiss - Delayed Quote CHF

Basilea Pharmaceutica AG (BSLN.SW)

Compare
42.10
-0.75
(-1.75%)
At close: January 10 at 5:30:32 PM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
173,289.00
220,848.00
247,267.00
229,794.00
Total Liabilities Net Minority Interest
183,291.00
241,562.00
305,874.00
331,840.00
Total Equity Gross Minority Interest
-10,002.00
-20,714.00
-58,607.00
-102,046.00
Total Capitalization
85,453.00
110,646.00
35,937.00
137,622.00
Common Stock Equity
-10,002.00
-20,714.00
-58,607.00
-102,046.00
Capital Lease Obligations
17,698.00
18,311.00
906.00
2,648.00
Net Tangible Assets
-10,550.00
-21,292.00
-59,239.00
-102,718.00
Working Capital
104,553.00
100,514.00
66,658.00
173,367.00
Invested Capital
100,906.00
148,113.00
159,442.00
137,622.00
Tangible Book Value
-10,550.00
-21,292.00
-59,239.00
-102,718.00
Total Debt
128,606.00
187,138.00
218,955.00
242,316.00
Net Debt
51,008.00
84,127.00
164,349.00
178,868.00
Share Issued
13,099.83
13,093.45
12,992.17
11,922.21
Ordinary Shares Number
12,001.67
11,951.30
11,842.03
10,867.31
Treasury Shares Number
1,098.16
1,142.14
1,150.13
1,054.90
12/31/2020 - 3/25/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers